Pharmaceutical composition of micronised progesterone and its use

摘要

A pharmaceutical composition (C1) comprises micronized progesterone and safflower oil type II. An independent claim is included for a pharmaceutical product comprising a composition (C1) where the product is in the form of a dosage unit of 2-600 mg of micronized progesterone. ACTIVITY : Gynecological; Osteopathic; Cytostatic; Anticonvulsant. No biological data given. MECHANISM OF ACTION : None given.